Profil bibliographique

Rowan Miller

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

215Publications signalées

4056Citations signalées

7Affiliations récentes

Les institutions déclarées

University College Hospital St Bartholomew's Hospital University College London Hospitals NHS Foundation Trust Queen Mary University of London Barts Health NHS Trust National Institute for Health and Care Research University College London

Les domaines associés

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapyChromatin Remodeling and CancerEndometrial and Cervical Cancer TreatmentsCancer Mechanisms and Therapy

Les publications récentes

2026 conference-abstract OpenAlex

CO101 MEAN OVERALL SURVIVAL FROM THE PHASE 3 MIRASOL TRIAL OF MIRVETUXIMAB SORAVTANSINE VS INVESTIGATOR’S CHOICE OF CHEMOTHERAPY IN WOMEN WITH FR?-HIGH PLATINUM-RESISTANT OVARIAN CANCER (GOG 3045/ENGOT-OV55; NCT04209855)

Casey Cosgrove, Rowan Miller, Eleonora Teplinsky, Paolo Scollo et autres

us, gb, it, be, pl, nl, il, fr, tw, es, kr, cz (code pays fourni par la source)

0 citations Value in Health

2026 article OpenAlex

MEAN OVERALL SURVIVAL FROM THE PHASE 3 MIRASOL TRIAL OF MIRVETUXIMAB SORAVTANSINE VS INVESTIGATOR'S CHOICE OF CHEMOTHERAPY IN WOMEN WITH FR?-HIGH PLATINUM-RESISTANT OVARIAN CANCER (GOG 3045/ENGOT-OV55; NCT04209855)

Casey Cosgrove, Rowan Miller, Eleonora Teplinsky, Paolo Scollo et autres

0 citations Lirias

Accès ouvert 2026 article OpenAlex

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer

Yvette Drew, Lucy Gilbert, Alejandro Martínez Bueno, Ana Oaknin et autres

ca, es, us, gb (code pays fourni par la source)

2 citations British Journal of Cancer

2026 article OpenAlex

Evolving management and fertility outcomes in ovarian germ cell tumours: A 27-year retrospective cohort study

Tanith Westerman, Shanthini Mary Crusz, Alison Berner, Rowan Miller et autres

gb (code pays fourni par la source)

0 citations International Journal of Gynecological Cancer

2026 article OpenAlex

Real-world outcomes at 3 years follow-up of olaparib first line maintenance treatment in patients with BRCA-mutated advanced ovarian cancer: results from the United Kingdom

Rowan Miller, Rosalind Glasspool, Gordon C. Jayson, Juan López-Báez et autres

gb (code pays fourni par la source)

0 citations International Journal of Gynecological Cancer

2026 article OpenAlex

Real-world outcomes in clear cell gynaecological cancer: impact on survival with bevacizumab-containing regimens at two UK tertiary centres

Bliss Anderson, Hannah Cheneylowe, Mahfooz Basha, Rowan Miller et autres

gb (code pays fourni par la source)

0 citations International Journal of Gynecological Cancer

2026 article OpenAlex

A ten-year retrospective analysis of the clinical outcomes of epithelial ovarian cancer patients recruited to UCLH’s early-phase trials unit.

Lorna J. Stillie, Ahmed Abbass, Uma Mukherjee, Rowan Miller et autres

gb (code pays fourni par la source)

0 citations International Journal of Gynecological Cancer

2026 article OpenAlex

Long-term outcomes in patients with platinum-sensitive recurrent ovarian cancer receiving ≥ 2 year duration of maintenance PARP inhibitor therapy

Apini Patel, Rowan Miller, Jonathan A. Ledermann, Michael J. Flynn et autres

gb (code pays fourni par la source)

0 citations International Journal of Gynecological Cancer

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Appendix 1 from Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study

Ana Oaknin, Bhavana Pothuri, Lucy Gilbert, Renaud Sabatier et autres

0 citations

2025 article OpenAlex

RACIAL SUBGROUP ANALYSES OF TUMOR RESPONSE AND SAFETY IN PATIENTS WITH MISMATCH REPAIR-DEFICIENT/MICROSATELLITE INSTABILITY-HIGH ADVANCED/RECURRENT ENDOMETRIAL CANCER RECEIVING DOSTARLIMAB MONOTHERAPY IN THE GARNET TRIAL

Anna V. Tinker, Renaud Sabatier, Bhavana Pothuri, Jubilee Brown et autres

ca, fr, us, gb, es, ie (code pays fourni par la source)

0 citations International Journal of Gynecological Cancer

2025 article OpenAlex

POST-OPERATIVE HORMONAL THERAPY VERSUS CHEMOTHERAPY IN STAGE II-IV LOW-GRADE SEROUS OVARIAN CARCINOMA: A TWO-CENTRE RETROSPECTIVE ANALYSIS

Hannah Bruhn, Jonas Repkewitz, Michael Devlin, Shanthini Mary Crusz et autres

gb (code pays fourni par la source)

0 citations International Journal of Gynecological Cancer

Accès ouvert 2025 article OpenAlex

P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive Surgery

Michail Sideris, Mark Brincat, Oleg Blyuss, Samuel Oxley et autres

gb, ru (code pays fourni par la source)

0 citations Cancers

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.